Jarushka Naidoo, MRCPI
2019 LCFA/IASLC/BMS Young Investigator
Dr. Jarushka Naidoo is a consultant medical oncologist at Beaumont Hospital in Dublin, Ireland. She is a clinical/translational investigator, specializing in immunotherapy for lung cancer, and immune-related toxicity. Dr. Naidoo’s research focus is on identifying novel biomarkers of response and toxicity to immunotherapy, and specifically for patients with lung cancer.
Dr. Naidoo’s LCFA Funded Project
Dr. Naidoo’s project for the LCFA/IASLC/BMS Young Investigator grant in immuno-oncology, aims to identify whether a patient’s gut microbiome is implicated in their ability to derive benefit, or develop toxicity, from anti-PD-1/PD-L1 immunotherapy in lung cancer.